175 related articles for article (PubMed ID: 16973623)
1. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.
Milakovic T; Quintanilla RA; Johnson GV
J Biol Chem; 2006 Nov; 281(46):34785-95. PubMed ID: 16973623
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.
Quintanilla RA; Jin YN; von Bernhardi R; Johnson GV
Mol Neurodegener; 2013 Dec; 8():45. PubMed ID: 24330821
[TBL] [Abstract][Full Text] [Related]
3. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.
Choo YS; Johnson GV; MacDonald M; Detloff PJ; Lesort M
Hum Mol Genet; 2004 Jul; 13(14):1407-20. PubMed ID: 15163634
[TBL] [Abstract][Full Text] [Related]
4. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
5. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.
Ruan Q; Lesort M; MacDonald ME; Johnson GV
Hum Mol Genet; 2004 Apr; 13(7):669-81. PubMed ID: 14962977
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.
Siddiqui A; Rivera-Sánchez S; Castro Mdel R; Acevedo-Torres K; Rane A; Torres-Ramos CA; Nicholls DG; Andersen JK; Ayala-Torres S
Free Radic Biol Med; 2012 Oct; 53(7):1478-88. PubMed ID: 22709585
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin.
Milakovic T; Johnson GV
J Biol Chem; 2005 Sep; 280(35):30773-82. PubMed ID: 15983033
[TBL] [Abstract][Full Text] [Related]
8. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
Oliveira JM
J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
[TBL] [Abstract][Full Text] [Related]
9. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.
Ruan Q; Quintanilla RA; Johnson GV
J Neurochem; 2007 Jul; 102(1):25-36. PubMed ID: 17403029
[TBL] [Abstract][Full Text] [Related]
10. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
Quintanilla RA; Jin YN; Fuenzalida K; Bronfman M; Johnson GVW
J Biol Chem; 2008 Sep; 283(37):25628-25637. PubMed ID: 18640979
[TBL] [Abstract][Full Text] [Related]
12. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors.
Oliveira JM; Chen S; Almeida S; Riley R; Gonçalves J; Oliveira CR; Hayden MR; Nicholls DG; Ellerby LM; Rego AC
J Neurosci; 2006 Oct; 26(43):11174-86. PubMed ID: 17065457
[TBL] [Abstract][Full Text] [Related]
14. Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats.
Gellerich FN; Gizatullina Z; Nguyen HP; Trumbeckaite S; Vielhaber S; Seppet E; Zierz S; Landwehrmeyer B; Riess O; von Hörsten S; Striggow F
J Biol Chem; 2008 Nov; 283(45):30715-24. PubMed ID: 18606820
[TBL] [Abstract][Full Text] [Related]
15. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
Panov AV; Gutekunst CA; Leavitt BR; Hayden MR; Burke JR; Strittmatter WJ; Greenamyre JT
Nat Neurosci; 2002 Aug; 5(8):731-6. PubMed ID: 12089530
[TBL] [Abstract][Full Text] [Related]
16. Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.
Mao Z; Choo YS; Lesort M
Eur J Neurosci; 2006 Apr; 23(7):1701-10. PubMed ID: 16623826
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease.
Brustovetsky N; LaFrance R; Purl KJ; Brustovetsky T; Keene CD; Low WC; Dubinsky JM
J Neurochem; 2005 Jun; 93(6):1361-70. PubMed ID: 15935052
[TBL] [Abstract][Full Text] [Related]
18. Reduced mitochondrial complex II activity enhances cell death via intracellular reactive oxygen species in STHdhQ111 striatal neurons with mutant huntingtin.
Okada N; Yako T; Nakamura S; Shimazawa M; Hara H
J Pharmacol Sci; 2021 Dec; 147(4):367-375. PubMed ID: 34663519
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
[TBL] [Abstract][Full Text] [Related]
20. Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism.
Lee JM; Ivanova EV; Seong IS; Cashorali T; Kohane I; Gusella JF; MacDonald ME
PLoS Genet; 2007 Aug; 3(8):e135. PubMed ID: 17708681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
